drugset / Trial / NCT05983354

Oral Medications for the Management of Acute Migraine Headache in the Emergency Department

NCT05983354

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this pilot randomized control trial is to assess the feasibility of our patient recruitment and data collection strategy ahead of a full scale RCT investigating the efficacy of oral v. parenteral medications in the management of acute migraine headaches in the emergency department. Patients will be randomly assigned to receive either (A) standard medical therapy for the treatment of acute migraine headache (metoclopramide and ketorolac IV) and oral placebo or (B) oral metoclopramide and ibuprofen with normal saline IV. Primary outcome measures are recruitment rate and improvement in pain score at 60 minutes from medication administration.

Timeline

Start
2024-01-01
Primary completion
2024-06-30
Completion
2024-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg Oral
Comparator Ketorolac Other / unclassified 10 mg Intravenous
Subject Metoclopramide Small molecule 10 mg Oral

Indications